bioAffinity Technologies (BIAF) Notes Payables (2022 - 2025)
Historic Notes Payables for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $136396.0.
- bioAffinity Technologies' Notes Payables fell 4893.08% to $136396.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136396.0, marking a year-over-year decrease of 4893.08%. This contributed to the annual value of $171669.0 for FY2024, which is N/A changed from last year.
- Latest data reveals that bioAffinity Technologies reported Notes Payables of $136396.0 as of Q3 2025, which was down 4893.08% from $32946.0 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Notes Payables ranged from a high of $325000.0 in Q3 2022 and a low of $4106.0 during Q2 2024
- Its 3-year average for Notes Payables is $130831.2, with a median of $120581.0 in 2025.
- Over the last 5 years, bioAffinity Technologies' Notes Payables had its largest YoY gain of 213572.34% in 2025, and its largest YoY loss of 4893.08% in 2025.
- bioAffinity Technologies' Notes Payables (Quarter) stood at $325000.0 in 2022, then crashed by 47.18% to $171669.0 in 2024, then dropped by 20.55% to $136396.0 in 2025.
- Its Notes Payables was $136396.0 in Q3 2025, compared to $32946.0 in Q2 2025 and $104766.0 in Q1 2025.